Hubert Walinski
Director/Board Member bei CIPHER PHARMACEUTICALS INC.
Vermögen: - $ am 31.03.2024
Profil
Hubert Walinski is currently an Independent Director at Cipher Pharmaceuticals, Inc. and the Chief Scientific Officer at Aic Global Holdings, Inc. Previously, he worked as the Head-Medical Respiratory, Immunology & Vaccines at AstraZeneca Canada, Inc. Mr. Walinski holds a doctorate degree from the University of British Columbia, which he obtained in 2007.
He also has an undergraduate degree from McMaster University, which he received in 2001.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Hubert Walinski
| Unternehmen | Position | Beginn |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Director/Board Member | 21.06.2023 |
| Aic Global Holdings, Inc. | Chief Tech/Sci/R&D Officer | 01.08.2021 |
Ehemalige bekannte Positionen von Hubert Walinski
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 01.07.2021 |
Ausbildung von Hubert Walinski
| University of British Columbia | Doctorate Degree |
| McMaster University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
| Aic Global Holdings, Inc. |
